There are more than 10,000 new liver cancer patients in Taiwan every year, and one-third of them cannot be cured by local treatments such as surgery and electrocautery. They must rely on targeted drugs, immune drugs or radiation therapy. In recent years, “immune combination therapy” has made new breakthroughs! Multinational studies have shown that compared with traditional targeted therapy, the combined use of first-line immune drugs and anti-angiogenic drugs not only doubles the tumor response rate, but also reduces the risk of cancer death by more than 40%. choose.
A middle-aged man went to the emergency room because of severe abdominal pain. He thought it was appendicitis, but the examination revealed that it was liver cancer, and it was already at an advanced stage. The doctor pointed out that early-stage liver cancer can be treated with radical treatment such as surgery or electrocautery.
If the tumor has metastasized or cannot be operated on, in addition to using targeted drugs or immune drugs alone, or with radiation therapy, immune combination therapy is expected to become the first. A new option for line therapy.
Studies have shown that compared with traditional targeted therapy, the combined use of immune drugs and anti-angiogenic targeted drugs in the first line not only doubles the tumor response rate, but also significantly improves the overall survival and disease-free survival of patients.
Dr. Chen Yanyang, director of the Department of Hematology and Oncology at Kaohsiung Chang Gung Hospital, pointed out that there are no nerves in the liver, but only on the surface of the liver. If the tumor in the liver does not invade the surface, there will be no symptoms of pain, and if the tumor is not large enough, or if it is not affected Influenced by external forces such as violent collisions, most patients have no obvious symptoms. Once patients develop fatigue, loss of appetite, weight loss, upper abdominal pain, abnormal liver function, jaundice, abdominal enlargement, and even upper gastrointestinal bleeding, vomiting and other clinical symptoms of liver cancer, most It is late